₹114.97
▲ +0.29 +0.25%
As of 22 Sept 2026 · delayed
NSE Listed · Healthcare
Lotus Eye Hospital & Institute Ltd. (LOTUSEYE)
20-day avg volume: 13K shares
- Company is almost debt-free.
- Stock trades at a high P/E of 1437.
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹14 Cr | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹17 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹39 Cr | ₹41 Cr | ₹33 Cr | ₹40 Cr | ₹48 Cr | ₹50 Cr | ₹51 Cr | ₹55 Cr |
| EBITDA | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹6 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹0 Cr |
| EPS | 0.34 | 0.51 | 0.75 | 1.44 | 1.96 | 1.4 | 0.36 | 0.04 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹57 Cr | ₹58 Cr | ₹59 Cr | ₹62 Cr | ₹63 Cr | ₹67 Cr | ₹70 Cr | ₹83 Cr |
| Total Liabilities | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹10 Cr | ₹22 Cr |
| Equity | ₹50 Cr | ₹51 Cr | ₹53 Cr | ₹55 Cr | ₹58 Cr | ₹59 Cr | ₹60 Cr | ₹60 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹3 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹3 Cr | ₹3 Cr |
| Investing | ₹0 Cr | ₹-4 Cr | ₹-2 Cr | ₹-4 Cr | ₹-4 Cr | ₹-12 Cr |
| Financing | ₹0 Cr | ₹-2 Cr | ₹-2 Cr | ₹-3 Cr | ₹-2 Cr | ₹9 Cr |
| Free Cash Flow | ₹3 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹3 Cr | ₹3 Cr |
Healthcare · Medical Care Facilities
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
www.lotuseye.org ↗As of 2026-06-30
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.6% | 56.6% | 41.4% | 40.2% | 40% | 40.1% | 40.2% | 40.4% | 40.6% | 40.7% | 40.1% | 40.1% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 42.4% | 43.4% | 58.6% | 59.8% | 59.9% | 59.8% | 59.7% | 59.6% | 59.3% | 59.3% | 59.8% | 59.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 87.2% | 87.2% |
| No. of Shareholders | 7,660 | 8,314 | 12,502 | 11,759 | 12,514 | 11,734 | 11,508 | 11,121 | 10,777 | 10,240 | 9,939 | 9,627 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sangeetha S | Shareholding of Promoter and Promoter Group | 35% | 72,74,272 |
| Kovai Purani Finance Private Limited | Public Shareholding | 7.9% | 16,49,578 |
| Vramath Investment Consultancy Private Limited | Public Shareholding | 4.8% | 10,06,744 |
| Vramath Financial Services Private Limited | Public Shareholding | 4.7% | 9,71,873 |
| Rajiv Choudhary | Public Shareholding | 4.5% | 9,42,005 |
| Sangeeta Choudhary | Public Shareholding | 3.9% | 8,15,000 |
| Kavetha Sundaramoorthy | Shareholding of Promoter and Promoter Group | 2.8% | 5,70,993 |
| Thomas Santosh | Public Shareholding | 2.7% | 5,52,202 |
| Late Kaliannagounder Sundaramoorthy | Shareholding of Promoter and Promoter Group | 2.4% | 5,01,837 |
| Mahendran Devika | Public Shareholding | 2% | 4,09,522 |
| K S Ramalingam | Public Shareholding | 1.5% | 3,02,894 |
| Urvija Choudhary | Public Shareholding | 1.4% | 2,95,319 |
| Madhavi Rubin Chheda | Public Shareholding | 1.1% | 2,20,000 |
| Sundaramoorthy Rajkumar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Asean Optics Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Eyeda Meds Llp | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dr S K S Memorial Eye Hospitals Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Sangeetha S | 72,74,272 | 100% | 2026-06-30 |
| Name | Designation | Year |
|---|---|---|
| Sangeetha Sundaramoorthy | ED / MD / Promoter | 2025 |
| Kaveetha Sundaramoorthy | Chairman & Non Executive Dir. | 2025 |
| K.S. Ramalingam | Executive Director / Whole Time Director / CEO | 2025 |
| S Natesan | Independent Non Exe. Director | 2025 |
| Karthik Veeramani | Independent Non Exe. Director | 2025 |
| Perumalsamy Mahendran | Independent Non Exe. Director | 2025 |
| M Achuth menon, | Company Sec. & Compli. Officer | 2025 |
| Segment | Revenue | Share |
|---|---|---|
| Healthcare activities | ₹0 Cr | — |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 25 | 21 | 21 |
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-10 | Board Meetings | — |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 2 | 2 |
| 2026 | 0 | 0 | 0 | 0 | 2 | 2 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
8 recent disclosure(s)
3 disclosure(s)
📍 SF No770/12 Civil Aerodrome(P), Avinashi Road, Coimbatore, Tamil Nadu, 641014
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search